Drawing for VERACITY

USPTO serial 79185269

VERACITY

Reviewed by CopyMark Law Group

Reg. 5080113Status 739Renewal
Filing date
Status date
Registration date
Nov 15, 2016
Examiner
PARKS, KIMBERLY L
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with VERACITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Paulo A. de Almeida

Paulo A. de Almeida Patel & Almeida PC22543 Ventura Blvd, Ste 220 #1200Woodland Hills, CA 91364UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical laboratory services for testing of fetal genetic abnormalities during pregnancyACTIVE—
044Medical testing of blood for diagnosis of fetal genetic abnormalities during pregnancyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 15, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Aug 28, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 16, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 2, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 29, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 24, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 24, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 24, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 19, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
Nov 15, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 4, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 30, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 30, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 15, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 15, 2016FIMPFINAL DISPOSITION PROCESSED—
Dec 15, 2016GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Nov 15, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 7, 2016ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 23, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 23, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 24, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 24, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 4, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 15, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 12, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 6, 2016DOCKASSIGNED TO EXAMINER—
Apr 1, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance